DexCom Historical Balance Sheet

DXCM Stock

USD 73.80 1.31 1.74%

Trend analysis of DexCom Inc balance sheet accounts such as Net Debt of 2 B or Cash of 636.4 M provides information on DexCom's total assets, liabilities, and equity, which is the actual value of DexCom Inc to its prevalent stockholders. By breaking down trends over time using DexCom balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining DexCom Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether DexCom Inc is a good buy for the upcoming year.

DexCom Inventory

569.73 Million

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

About DexCom Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of DexCom Inc at a specified time, usually calculated after every quarter, six months, or one year. DexCom Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of DexCom and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which DexCom currently owns. An asset can also be divided into two categories, current and non-current.

DexCom Balance Sheet Chart

At this time, DexCom's Total Current Assets are very stable compared to the past year. As of the 23rd of March 2025, Total Current Liabilities is likely to grow to about 3.1 B, while Other Current Liabilities is likely to drop about 66.2 M.

Total Assets Common Stock Shares Outstanding Total Current Assets Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of DexCom assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in DexCom Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.

Total Current Liabilities

Total Current Liabilities is an item on DexCom balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of DexCom Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from DexCom's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into DexCom Inc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	753.4M	1.2B	69.7M	66.2M
Total Current Assets	3.7B	4.4B	4.3B	4.5B

Other Current Liab Total Current Assets

DexCom balance sheet Correlations

	Total Assets	Total Stockholder Equity	Net Debt	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Total Current Assets	Other Current Liab	Total Current Liabilities	Property Plant And Equipment Net	Retained Earnings	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Common Stock Total Equity	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Common Stock	Property Plant Equipment	Other Liab	Short Term Investments	Short Long Term Debt Total
Total Assets		0.98	0.96	0.7	0.97	0.54	0.99	0.62	0.9	0.98	0.83	0.72	0.98	0.63	0.97	0.85	0.91	0.97	0.39	0.99	0.95	0.85	0.98	0.94	0.98	0.99
Total Stockholder Equity	0.98		0.91	0.75	0.98	0.6	0.99	0.65	0.82	0.95	0.75	0.62	0.93	0.52	0.93	0.76	0.92	0.94	0.52	0.96	0.88	0.76	0.95	0.97	0.98	0.97
Net Debt	0.96	0.91		0.49	0.88	0.43	0.94	0.62	0.92	0.97	0.9	0.75	0.97	0.67	0.97	0.9	0.84	0.98	0.21	0.97	0.97	0.9	0.96	0.86	0.95	0.95
Cash	0.7	0.75	0.49		0.82	0.59	0.75	0.42	0.44	0.6	0.28	0.33	0.56	0.23	0.54	0.35	0.79	0.56	0.74	0.66	0.5	0.35	0.6	0.71	0.66	0.73
Cash And Short Term Investments	0.97	0.98	0.88	0.82		0.6	0.99	0.64	0.77	0.91	0.68	0.59	0.89	0.48	0.89	0.7	0.96	0.9	0.59	0.94	0.83	0.7	0.9	0.94	0.97	0.98
Common Stock Shares Outstanding	0.54	0.6	0.43	0.59	0.6		0.57	0.53	0.33	0.48	0.14	0.15	0.45	0.05	0.44	0.4	0.6	0.47	0.73	0.5	0.39	0.4	0.49	0.53	0.54	0.54
Total Current Assets	0.99	0.99	0.94	0.75	0.99	0.57		0.64	0.85	0.96	0.78	0.67	0.95	0.58	0.94	0.8	0.94	0.95	0.47	0.98	0.91	0.8	0.96	0.94	0.98	1.0
Other Current Liab	0.62	0.65	0.62	0.42	0.64	0.53	0.64		0.35	0.57	0.39	-0.02	0.56	-0.12	0.59	0.48	0.77	0.6	0.48	0.6	0.48	0.48	0.59	0.6	0.66	0.63
Total Current Liabilities	0.9	0.82	0.92	0.44	0.77	0.33	0.85	0.35		0.95	0.95	0.91	0.96	0.87	0.94	0.95	0.65	0.94	0.02	0.92	0.98	0.95	0.94	0.79	0.83	0.87
Property Plant And Equipment Net	0.98	0.95	0.97	0.6	0.91	0.48	0.96	0.57	0.95		0.9	0.78	1.0	0.71	0.98	0.91	0.84	0.98	0.26	0.99	0.98	0.91	1.0	0.91	0.95	0.97
Retained Earnings	0.83	0.75	0.9	0.28	0.68	0.14	0.78	0.39	0.95	0.9		0.85	0.92	0.83	0.92	0.91	0.6	0.9	-0.18	0.87	0.95	0.91	0.89	0.75	0.77	0.8
Accounts Payable	0.72	0.62	0.75	0.33	0.59	0.15	0.67	-0.02	0.91	0.78	0.85		0.8	0.99	0.75	0.8	0.44	0.76	-0.16	0.76	0.86	0.8	0.77	0.61	0.63	0.7
Non Current Assets Total	0.98	0.93	0.97	0.56	0.89	0.45	0.95	0.56	0.96	1.0	0.92	0.8		0.73	0.99	0.93	0.81	0.99	0.21	0.98	0.98	0.93	1.0	0.9	0.93	0.95
Non Currrent Assets Other	0.63	0.52	0.67	0.23	0.48	0.05	0.58	-0.12	0.87	0.71	0.83	0.99	0.73		0.69	0.76	0.32	0.69	-0.28	0.68	0.81	0.76	0.69	0.53	0.54	0.61
Other Assets	0.97	0.93	0.97	0.54	0.89	0.44	0.94	0.59	0.94	0.98	0.92	0.75	0.99	0.69		0.91	0.81	0.99	0.22	0.97	0.96	0.91	0.98	0.92	0.94	0.94
Common Stock Total Equity	0.85	0.76	0.9	0.35	0.7	0.4	0.8	0.48	0.95	0.91	0.91	0.8	0.93	0.76	0.91		0.62	0.91	0.0	0.88	0.94	1.0	0.91	0.7	0.77	0.82
Non Current Liabilities Total	0.91	0.92	0.84	0.79	0.96	0.6	0.94	0.77	0.65	0.84	0.6	0.44	0.81	0.32	0.81	0.62		0.83	0.6	0.89	0.77	0.62	0.83	0.87	0.93	0.93
Other Current Assets	0.97	0.94	0.98	0.56	0.9	0.47	0.95	0.6	0.94	0.98	0.9	0.76	0.99	0.69	0.99	0.91	0.83		0.26	0.98	0.96	0.91	0.98	0.91	0.95	0.96
Other Stockholder Equity	0.39	0.52	0.21	0.74	0.59	0.73	0.47	0.48	0.02	0.26	-0.18	-0.16	0.21	-0.28	0.22	0.0	0.6	0.26		0.31	0.09	0.0	0.27	0.46	0.46	0.42
Total Liab	0.99	0.96	0.97	0.66	0.94	0.5	0.98	0.6	0.92	0.99	0.87	0.76	0.98	0.68	0.97	0.88	0.89	0.98	0.31		0.97	0.88	0.98	0.91	0.96	0.99
Property Plant And Equipment Gross	0.95	0.88	0.97	0.5	0.83	0.39	0.91	0.48	0.98	0.98	0.95	0.86	0.98	0.81	0.96	0.94	0.77	0.96	0.09	0.97		0.94	0.97	0.84	0.89	0.93
Common Stock	0.85	0.76	0.9	0.35	0.7	0.4	0.8	0.48	0.95	0.91	0.91	0.8	0.93	0.76	0.91	1.0	0.62	0.91	0.0	0.88	0.94		0.91	0.7	0.77	0.82
Property Plant Equipment	0.98	0.95	0.96	0.6	0.9	0.49	0.96	0.59	0.94	1.0	0.89	0.77	1.0	0.69	0.98	0.91	0.83	0.98	0.27	0.98	0.97	0.91		0.91	0.94	0.96
Other Liab	0.94	0.97	0.86	0.71	0.94	0.53	0.94	0.6	0.79	0.91	0.75	0.61	0.9	0.53	0.92	0.7	0.87	0.91	0.46	0.91	0.84	0.7	0.91		0.94	0.92
Short Term Investments	0.98	0.98	0.95	0.66	0.97	0.54	0.98	0.66	0.83	0.95	0.77	0.63	0.93	0.54	0.94	0.77	0.93	0.95	0.46	0.96	0.89	0.77	0.94	0.94		0.98
Short Long Term Debt Total	0.99	0.97	0.95	0.73	0.98	0.54	1.0	0.63	0.87	0.97	0.8	0.7	0.95	0.61	0.94	0.82	0.93	0.96	0.42	0.99	0.93	0.82	0.96	0.92	0.98

Click cells to compare fundamentals

DexCom Account Relationship Matchups

DexCom balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	4.3B	4.9B	5.4B	6.3B	6.5B	6.8B
Total Stockholder Equity	1.8B	2.3B	2.1B	2.1B	2.1B	2.2B
Net Debt	1.0B	769.2M	1.4B	2.0B	1.9B	2.0B
Cash	817.6M	1.1B	642.3M	566.3M	606.1M	636.4M
Cash And Short Term Investments	2.7B	2.7B	2.5B	2.7B	2.6B	2.7B
Common Stock Shares Outstanding	390M	428.8M	427.5M	425.5M	412.7M	254.7M
Liabilities And Stockholders Equity	4.3B	4.9B	5.4B	6.3B	6.5B	6.8B
Total Current Assets	3.4B	3.7B	3.7B	4.4B	4.3B	4.5B
Other Current Liab	400.3M	447.6M	753.4M	1.2B	69.7M	66.2M
Total Current Liabilities	614.1M	720.8M	1.8B	1.6B	2.9B	3.1B
Property Plant And Equipment Net	608.6M	889.9M	1.1B	1.2B	1.4B	1.5B
Retained Earnings	(202.1M)	(47.4M)	479.9M	1.0B	1.6B	1.7B
Accounts Payable	163.3M	189.4M	237.9M	276.4M	1.6B	1.7B
Non Current Assets Total	865.7M	1.2B	1.7B	1.8B	2.2B	2.3B
Non Currrent Assets Other	21.4M	(4.5M)	28.1M	36.5M	654.2M	686.9M
Other Assets	14.2M	237.8M	220.8M	369.3M	424.7M	445.9M
Non Current Liabilities Total	1.8B	1.9B	1.4B	2.6B	1.4B	1.5B
Other Current Assets	107.8M	79.3M	153.7M	154.7M	173.7M	182.4M
Other Stockholder Equity	2.0B	1.9B	1.7B	1.1B	512.6M	538.2M
Total Liab	2.5B	2.6B	3.3B	4.2B	4.4B	4.6B
Property Plant And Equipment Gross	608.6M	801.8M	1.1B	1.7B	2.1B	2.2B
Accumulated Other Comprehensive Income	3.2M	500K	(11.6M)	(16.7M)	(8M)	(7.6M)
Property Plant Equipment	321.3M	515.3M	889.9M	1.1B	1.3B	1.4B
Other Liab	5.7M	80.9M	90M	68.7M	79.0M	83.0M
Short Term Investments	1.9B	1.7B	1.8B	2.2B	2.0B	2.1B
Short Long Term Debt Total	1.8B	1.8B	2.1B	2.6B	2.5B	2.7B
Long Term Debt	1.7B	1.7B	1.2B	2.4B	1.2B	661.2M
Net Receivables	428.5M	516.6M	752.2M	987.5M	1.0B	1.1B
Inventory	234.7M	357.3M	306.7M	559.6M	542.6M	569.7M
Short Term Debt	33M	41M	793.1M	21.1M	1.2B	1.3B
Current Deferred Revenue	2.2M	2.1M	10.1M	18.4M	8M	4.7M
Net Tangible Assets	864M	1.8B	2.2B	2.1B	2.5B	2.6B
Good Will	19.3M	26.5M	25.7M	25.2M	22.8M	15.2M
Retained Earnings Total Equity	(695.7M)	(202.1M)	(47.4M)	479.9M	551.9M	579.5M
Capital Surpluse	1.7B	2.1B	2.5B	2.3B	2.6B	1.5B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:

How To Invest In DexCom

Details

Is DexCom Stock a good investment?

Details

What is DexCom's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.39)

Earnings Share

1.42

Revenue Per Share

10.246

Quarterly Revenue Growth

0.076

Return On Assets

0.0588

The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

DexCom Historical Balance Sheet

DexCom Inventory

569.73 Million

About DexCom Balance Sheet Analysis

DexCom Balance Sheet Chart

Total Assets

Common Stock Shares Outstanding

Total Current Assets

Total Current Liabilities

DexCom balance sheet Correlations

DexCom Account Relationship Matchups

High Positive Relationship

High Negative Relationship

DexCom balance sheet Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Short Long Term Debt Total	+ 1.0	Total Current Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Property Plant Equipment	+ 1.0	Property Plant And Equipment Net
Property Plant Equipment	+ 1.0	Non Current Assets Total
Common Stock	+ 1.0	Common Stock Total Equity
Total Current Assets	+ 0.99	Total Assets

Other Stockholder Equity	- 0.28	Non Currrent Assets Other
Other Stockholder Equity	- 0.18	Retained Earnings
Other Stockholder Equity	- 0.16	Accounts Payable
Non Currrent Assets Other	- 0.12	Other Current Liab
Accounts Payable	- 0.02	Other Current Liab
Common Stock	- 0.0	Other Stockholder Equity